Centrus Energy Corp. reported second-quarter 2025 revenue of $154.5 million, comfortably ahead of the $130.2 million consensus forecast. Adjusted earnings per share came in at $1.59, nearly double analysts’ $0.84 estimate. Net income slipped to $28.9 million from $30.6 million a year earlier, but gross profit rose 48 percent to $53.9 million. The uranium-enrichment company ended the quarter with $833 million in cash. The stronger-than-expected results prompted mixed reactions on Wall Street. Bank of America cut its rating to Neutral while lifting its price target to $285 from $210, citing the earnings beat but a more balanced risk-reward profile. JPMorgan boosted its target to $164 from $150 and maintained a Neutral stance, whereas Evercore ISI reiterated an Outperform rating and nudged its target to $252 from $251.
$PODD -Canaccord raises Insulet target to $353 from $331 Buy -RBC raises target to $350 from $330 Outperform -Wells Fargo raises target to $350 from $330 Overweight - $PRMB -RBC lowers Primo Brands target to $37 from $40 Outperform -TD Securities lower target to $35 from $48
$PLMR -Keefe Bruyette & Woods lower Palomar target to $172 from $204 Outperform - $PLRX -Piper Sandler lowers Pliant Therapeutics target to $4 from $17 Overweight - $PLTK -Wedbush lowers Playtika target to $7 from $11.50 Outperform -
$PINS -Citi raises Pinterest target to $50 from $44 Buy -Stifel to $47 from $46 Buy -Monness Crespi & Hardt to $46 from $40 Buy -Bank of America to $44 from $41 Buy -Wedbush to $44 from $42 Outperform -Piper Sandler to $35 from $34 Neutral -